Regencell Bioscience
5 hedge funds and large institutions have $260K invested in Regencell Bioscience in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$7K |
Top Sellers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$12K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$17K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Geode Capital Management
Boston,
Massachusetts
| $216K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $17K | -$5.43K | -6,650 | -24% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $12K | -$6.65K | -7,828 | -36% |
|
4
BlackRock
New York
| $8K | – | – | – |
|
|
5
Morgan Stanley
New York
| $7K | +$2.41K | +2,964 | +52% |
|